Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4XGR

Crystal structure of addiction module from Mycobacterial species

Summary for 4XGR
Entry DOI10.2210/pdb4xgr/pdb
Related4XGQ
DescriptorRibonuclease VapC30, Antitoxin VapB30, MAGNESIUM ION, ... (4 entities in total)
Functional Keywordsmycobacteria, addiction module, toxin-antitoxin complex, toxin/antitoxin
Biological sourceMycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
More
Total number of polymer chains8
Total formula weight95201.51
Authors
Lee, B.-J.,Lee, I.-G.,Lee, S.J. (deposition date: 2015-01-02, release date: 2015-08-12, Last modification date: 2024-10-16)
Primary citationLee, I.-G.,Lee, S.J.,Chae, S.,Lee, K.Y.,Kim, J.H.,Lee, B.-J.
Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin-antitoxin system: implications for the design of novel antimicrobial peptides
Nucleic Acids Res., 43:7624-7637, 2015
Cited by
PubMed Abstract: Toxin-antitoxin (TA) systems play important roles in bacterial physiology, such as multidrug tolerance, biofilm formation, and arrest of cellular growth under stress conditions. To develop novel antimicrobial agents against tuberculosis, we focused on VapBC systems, which encompass more than half of TA systems in Mycobacterium tuberculosis. Here, we report that theMycobacterium tuberculosis VapC30 toxin regulates cellular growth through both magnesium and manganese ion-dependent ribonuclease activity and is inhibited by the cognate VapB30 antitoxin. We also determined the 2.7-Å resolution crystal structure of the M. tuberculosis VapBC30 complex, which revealed a novel process of inactivation of the VapC30 toxin via swapped blocking by the VapB30 antitoxin. Our study on M. tuberculosis VapBC30 leads us to design two kinds of VapB30 and VapC30-based novel peptides which successfully disrupt the toxin-antitoxin complex and thus activate the ribonuclease activity of the VapC30 toxin. Our discovery herein possibly paves the way to treat tuberculosis for next generation.
PubMed: 26150422
DOI: 10.1093/nar/gkv689
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon